Hanmi Pharm launches complex treatment of rosuvastatin and ezetimibe

Published: 2015-11-16 10:06:02

Updated: 2015-11-16 10:06:02

Hanmi Pharm(CEO Kwan-soon Lee) launched ‘Rosuzet,’ a complex drug combining ‘rosuvastatin,’ a substance of hyperlipidemia treatment, and ‘ezetimibe’ for the first time in the world, the company announced on the 12^th. The combination of the two substances both inhibits cholesterol synthesis and hinder the absorption in small intestine.

In order to launch Rosuzet, Hanmi Pharm has made a license ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.